Compared to the stable CU Aβ− group, the emergent AD group had a slightly longer follow‐up, a higher prevalence of APOE ε4 carriage and higher education, and higher baseline Aβ burden (Table 1). This evidence concerns the gene APOE and Alzheimer disease.